8 Review of guidance

8.1 The guidance on this technology for people with STEMI will be incorporated into the forthcoming NICE clinical guideline on the management of myocardial infarction with ST-segment elevation.

8.2 The guidance on ticagrelor for people with NSTEMI and unstable angina will be considered for review at the same time as clinical guideline 94 (Unstable angina and NSTEMI: the early management of unstable angina and non-ST-segment elevation myocardial infarction), that is in March 2013.

Andrew Dillon

Chief Executive

October 2011

  • National Institute for Health and Care Excellence (NICE)